These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9101710)

  • 21. Therapeutic efficacy of liposomes containing 4-(5-pentadecyl-1,3,4-oxadiazol-2-yl)pyridine in a murine model of progressive pulmonary tuberculosis.
    Mata-Espinosa D; Molina-Salinas GM; Barrios-Payán J; Navarrete-Vázquez G; Marquina B; Ramos-Espinosa O; Bini EI; Baeza I; Hernández-Pando R
    Pulm Pharmacol Ther; 2015 Jun; 32():7-14. PubMed ID: 25843004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2005 Oct; 26(4):298-303. PubMed ID: 16154726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
    Litzinger DC; Huang L
    Biochim Biophys Acta; 1992 Feb; 1104(1):179-87. PubMed ID: 1550846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach.
    Buiting AM; Zhou F; Bakker JA; van Rooijen N; Huang L
    J Immunol Methods; 1996 Jun; 192(1-2):55-62. PubMed ID: 8699022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
    El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
    Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.
    Garg T; Goyal AK; Rath G; Murthy RS
    Pharm Dev Technol; 2016 Dec; 21(8):951-960. PubMed ID: 26334961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis.
    Gaspar MM; Cruz A; Penha AF; Reymão J; Sousa AC; Eleutério CV; Domingues SA; Fraga AG; Filho AL; Cruz ME; Pedrosa J
    Int J Antimicrob Agents; 2008 Jan; 31(1):37-45. PubMed ID: 18006283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
    Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
    Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large liposomes containing ganglioside GM1 accumulate effectively in spleen.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1991 Jul; 1066(2):159-65. PubMed ID: 1854781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum independent liposome uptake by mouse liver.
    Liu F; Liu D
    Biochim Biophys Acta; 1996 Jan; 1278(1):5-11. PubMed ID: 8611606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalable liposomes of Glycyrrhiza glabra extract for use in tuberculosis: formulation, in vitro characterization, in vivo lung deposition, and in vivo pharmacodynamic studies.
    Viswanathan V; Pharande R; Bannalikar A; Gupta P; Gupta U; Mukne A
    Drug Dev Ind Pharm; 2019 Jan; 45(1):11-20. PubMed ID: 30122088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution of liposomes in tuberculous mice.
    Orozco LC; Forero M; Wasserman M; Ahumada JJ
    Tubercle; 1990 Sep; 71(3):209-14. PubMed ID: 2238128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker.
    Anderson M; Paradis C; Omri A
    Drug Deliv; 2003; 10(3):193-200. PubMed ID: 12944140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is control of distribution of liposomes between tumors and bone marrow possible?
    Nagayasu A; Uchiyama K; Nishida T; Yamagiwa Y; Kawai Y; Kiwada H
    Biochim Biophys Acta; 1996 Jan; 1278(1):29-34. PubMed ID: 8611603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.